Amgen Inc.

$332.92 0.04%
NASDAQ: AMGN
Market Cap.: 178.9 B XL
P/E: 57.50 x34.30
EPS: 5.79 x 0.62
Earnings Call
1 month, 1 week from now
Dividend Waiting Time
n.A.
Latest Dividends History
Yield: 0.80%
Payout: -1069.03%
Volume Level
μ 2,067,925
1,299,360 Moderate Low
Performance Ranks (Intraday)
United States:

898th

out of

2160

Healthcare:

318th

out of

792

Drug Manufacturers—General:

21st

out of

62

Peer Group:

3rd

out of

8

About

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and …